Gallo Stephen A, Clore G Marius, Louis John M, Bewley Carole A, Blumenthal Robert
Laboratory of Experimental and Computational Biology, National Cancer Institute, National Institutes of Health, Frederick, Maryland 21702, USA.
Biochemistry. 2004 Jun 29;43(25):8230-3. doi: 10.1021/bi049957v.
Peptides derived from the N- (N-HR) and C- (C-HR) terminal heptad repeat regions adjacent to the fusion peptide and transmembrane domains, respectively, of human immunodeficiency virus (HIV)-1 gp41 inhibit HIV-1 viral envelope glycoproteins (Env)-mediated cell fusion specifically. The mechanism of HIV-1 Env-mediated cell fusion and its inhibition by agents that target the N- and C-HR regions was investigated. Priming experiments with Env-expressing cells indicate that the N-HR region but not the C-HR region is exposed by treatment with sCD4 at 31 degrees C, whereas both the N- and C-HR regions are exposed at 37 degrees C.
分别源自人免疫缺陷病毒(HIV)-1 gp41融合肽和跨膜结构域附近的N-(N-HR)和C-(C-HR)末端七肽重复区域的肽,可特异性抑制HIV-1病毒包膜糖蛋白(Env)介导的细胞融合。研究了HIV-1 Env介导的细胞融合机制及其被靶向N-和C-HR区域的试剂抑制的情况。用表达Env的细胞进行的引发实验表明,在31℃用可溶性CD4(sCD4)处理可使N-HR区域暴露,而C-HR区域不暴露,而在37℃时N-和C-HR区域均暴露。